Nanobiotix (XPAR:NANO) Days Sales Outstanding : 6.06 (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Nanobiotix Days Sales Outstanding?

Nanobiotix's average Accounts Receivable for the six months ended in Dec. 2023 was €1.00 Mil. Nanobiotix's Revenue for the six months ended in Dec. 2023 was €30.06 Mil. Hence, Nanobiotix's Days Sales Outstanding for the six months ended in Dec. 2023 was 6.06.

The historical rank and industry rank for Nanobiotix's Days Sales Outstanding or its related term are showing as below:

XPAR:NANO' s Days Sales Outstanding Range Over the Past 10 Years
Min: 0.57 Med: 96.62 Max: 2263
Current: 8.48

During the past 13 years, Nanobiotix's highest Days Sales Outstanding was 2263.00. The lowest was 0.57. And the median was 96.62.

XPAR:NANO's Days Sales Outstanding is ranked better than
95.86% of 893 companies
in the Biotechnology industry
Industry Median: 73.24 vs XPAR:NANO: 8.48

Nanobiotix's Days Sales Outstanding increased from Dec. 2022 (0.00) to Dec. 2023 (6.06).

Nanobiotix Days Sales Outstanding Historical Data

The historical data trend for Nanobiotix's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanobiotix Days Sales Outstanding Chart

Nanobiotix Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

96.62

266.45

2,263.00

6.11

Nanobiotix Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															-	-	-	-	6.06

Competitive Comparison of Nanobiotix's Days Sales Outstanding

For the Biotechnology subindustry, Nanobiotix's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nanobiotix's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanobiotix's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Nanobiotix's Days Sales Outstanding falls into.

Nanobiotix Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Nanobiotix's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.101	+	0.905)	/	2 )	/	30.058	*	365
=	0.503					/	30.058	*	365
=	6.11

Nanobiotix's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (1.09	+	0.905)	/	2 )	/	30.058	*	365 / 2
=	0.9975					/	30.058	*	365 / 2
=	6.06

Nanobiotix (XPAR:NANO) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Nanobiotix Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Nanobiotix's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanobiotix (XPAR:NANO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanobiotix SA (XPAR:NANO) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

NBTX:USA 5NR:Germany

Address

60 Rue de Wattignies, Paris, FRA, 75012

Website

https://www.nanobiotix.com

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. It develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Nanobiotix (XPAR:NANO) Headlines

No Headlines